Does NECITUMUMAB Cause Haemoptysis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Haemoptysis have been filed in association with NECITUMUMAB (Portrazza). This represents 1.4% of all adverse event reports for NECITUMUMAB.
5
Reports of Haemoptysis with NECITUMUMAB
1.4%
of all NECITUMUMAB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Haemoptysis From NECITUMUMAB?
Of the 5 reports, 2 (40.0%) resulted in death, 3 (60.0%) required hospitalization.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NECITUMUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NECITUMUMAB Cause?
Platelet count decreased (68)
Malignant neoplasm progression (54)
Rash (48)
Hypomagnesaemia (46)
Neutrophil count decreased (45)
Dermatitis acneiform (44)
Febrile neutropenia (30)
Decreased appetite (29)
Neutropenia (26)
Nausea (21)
What Other Drugs Cause Haemoptysis?
RIVAROXABAN (1,961)
ASPIRIN (1,255)
APIXABAN (846)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
Which NECITUMUMAB Alternatives Have Lower Haemoptysis Risk?
NECITUMUMAB vs NEDAPLATIN
NECITUMUMAB vs NEFAZODONE
NECITUMUMAB vs NEFOPAM
NECITUMUMAB vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG
NECITUMUMAB vs NELARABINE